Venus Concept (VERO) Competitors $2.21 -0.08 (-3.49%) Closing price 04:00 PM EasternExtended Trading$2.21 +0.00 (+0.05%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERO vs. CTCX, MHUA, LYRA, LFWD, CHEK, OSRH, PAVM, TNON, POAI, and INBSShould you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Carmell (CTCX), Meihua International Medical Technologies (MHUA), Lyra Therapeutics (LYRA), Lifeward (LFWD), Check-Cap (CHEK), OSR (OSRH), PAVmed (PAVM), Tenon Medical (TNON), Predictive Oncology (POAI), and Intelligent Bio Solutions (INBS). These companies are all part of the "medical equipment" industry. Venus Concept vs. Its Competitors Carmell Meihua International Medical Technologies Lyra Therapeutics Lifeward Check-Cap OSR PAVmed Tenon Medical Predictive Oncology Intelligent Bio Solutions Venus Concept (NASDAQ:VERO) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and valuation. Which has more volatility & risk, VERO or CTCX? Venus Concept has a beta of 0.05, suggesting that its share price is 95% less volatile than the S&P 500. Comparatively, Carmell has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. Does the media prefer VERO or CTCX? In the previous week, Venus Concept's average media sentiment score of 0.00 equaled Carmell'saverage media sentiment score. Company Overall Sentiment Venus Concept Neutral Carmell Neutral Do analysts rate VERO or CTCX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Venus Concept 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Carmell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is VERO or CTCX more profitable? Carmell has a net margin of 0.00% compared to Venus Concept's net margin of -68.77%. Carmell's return on equity of -217.50% beat Venus Concept's return on equity.Company Net Margins Return on Equity Return on Assets Venus Concept-68.77% -871.77% -61.92% Carmell N/A -217.50%-50.22% Do institutionals & insiders believe in VERO or CTCX? 87.4% of Venus Concept shares are owned by institutional investors. Comparatively, 24.2% of Carmell shares are owned by institutional investors. 28.0% of Venus Concept shares are owned by company insiders. Comparatively, 29.0% of Carmell shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has stronger earnings and valuation, VERO or CTCX? Carmell has lower revenue, but higher earnings than Venus Concept. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVenus Concept$64.83M0.05-$47M-$50.78-0.04Carmell$32.84K288.69-$15.44MN/AN/A SummaryCarmell beats Venus Concept on 7 of the 10 factors compared between the two stocks. Get Venus Concept News Delivered to You Automatically Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VERO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERO vs. The Competition Export to ExcelMetricVenus ConceptMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.26M$7.31B$6.18B$10.67BDividend YieldN/A1.14%5.72%4.86%P/E Ratio-0.0427.2629.0927.12Price / Sales0.0527.68584.14126.40Price / CashN/A22.2737.1261.42Price / Book0.515.2312.246.43Net Income-$47M$178.09M$3.33B$276.63M7 Day Performance-7.14%-1.70%-1.46%-2.60%1 Month Performance-4.33%1.07%5.03%0.31%1 Year Performance-65.64%0.77%61.45%30.63% Venus Concept Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VEROVenus ConceptN/A$2.21-3.5%N/A-55.1%$3.26M$64.83M-0.04410CTCXCarmellN/A$0.62-18.4%N/A+10.1%$12.96M$32.84K0.0014Gap DownMHUAMeihua International Medical Technologies1.553 of 5 stars$0.41+1.5%N/A-66.2%$12.95M$96.90M0.00620News CoverageLYRALyra Therapeutics2.7911 of 5 stars$7.58-4.3%$100.00+1,219.3%-44.0%$12.43M$1.53M-0.2650LFWDLifeward1.7191 of 5 stars$0.77+2.5%$9.00+1,070.4%-72.8%$12.07M$25.66M-0.2560Gap UpCHEKCheck-Cap0.5688 of 5 stars$2.04+6.6%N/A+6.8%$11.91MN/A-0.6880Short Interest ↓Gap DownOSRHOSRN/A$0.54-3.5%N/AN/A$11.74MN/A0.00N/APAVMPAVmed4.5658 of 5 stars$0.53-5.5%$20.00+3,709.5%-55.8%$11.51M$2.99M0.4590News CoverageShort Interest ↓Gap DownHigh Trading VolumeTNONTenon Medical1.1785 of 5 stars$1.20+6.7%$5.50+360.3%-71.1%$10.58M$3.28M-0.048News CoveragePOAIPredictive Oncology0.3315 of 5 stars$13.35-0.9%N/A-5.5%$10.15M$1.62M-4.3830Short Interest ↑INBSIntelligent Bio Solutions0.2773 of 5 stars$1.08+0.9%N/A-29.3%$9.81M$3.05M-0.5310Positive NewsAnalyst Downgrade Related Companies and Tools Related Companies CTCX Alternatives MHUA Alternatives LYRA Alternatives LFWD Alternatives CHEK Alternatives OSRH Alternatives PAVM Alternatives TNON Alternatives POAI Alternatives INBS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERO) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredWhat Wall Street Won’t Say Out LoudDiscover the 7 key indicators before everyone else doesAmerican Alternative | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredTrump cannot stop this trainThe Nobel Committee just confirmed what free-market thinkers have long argued — that true wealth isn’t built t...Porter & Company | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venus Concept Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Venus Concept With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
